Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2019 | $1,954,481 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2010 | $1,951,103 | | enterprise zone |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2021 | $1,950,000 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2017 | $1,939,088 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2020 | $1,927,300 | | enterprise zone |
Sanofi Aventis US Inc. | Sanofi | Pennsylvania | state | 2008 | $1,925,940 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | New York | local | 2004 | $1,919,713 | | tax credit/rebate; property tax abatement |
Moderna Therapeutics, Inc. | Moderna Inc. | Massachusetts | state | 2016 | $1,875,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $1,875,000 | | tax credit/rebate |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2002 | $1,866,487 | | grant |
GlaxoSmithKline Beecham Corp | GlaxoSmithKline | North Carolina | state | 2005 | $1,859,000 | | grant |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2013 | $1,852,421 | | tax credit/rebate; property tax abatement |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2014 | $1,844,082 | | tax credit/rebate |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |
Biogen Idec MA, Inc | Biogen | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Arizona | state | 2018 | $1,820,000 | | tax credit/rebate |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2017 | $1,817,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2004 | $1,812,000 | | grant |
Kite Pharma, Inc. | Gilead Sciences | California | state | 2015 | $1,800,000 | | tax credit/rebate |
Amgen Inc. | Amgen | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2015 | $1,800,000 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2012 | $1,796,389 | | tax increment financing |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2017 | $1,773,000 | | tax credit/rebate |
MERCK SHARP & DOHME CORP | Merck | Pennsylvania | state | 2020 | $1,759,300 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $1,749,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2021 | $1,725,000 | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $1,715,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2018 | $1,712,426 | | tax credit/rebate |
SPARK THERAPEUTICS, LLC | Roche | Pennsylvania | state | 2020 | $1,687,300 | | tax credit/rebate |
Cephalon | Teva Pharmaceutical Industries | Utah | state | 2009 | $1,683,200 | | tax credit/rebate |
Merck & Co., Inc. | Merck | Pennsylvania | state | 2009 | $1,677,793 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2010 | $1,665,848 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $1,653,115 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2018 | $1,650,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2020 | $1,629,414 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2009 | $1,617,030 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2008 | $1,605,983 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2009 | $1,605,983 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2010 | $1,605,983 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Novartis | Novartis | New Jersey | state | 2006 | $1,588,500 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2017 | $1,583,114 | | enterprise zone |
Merck & Co., Inc. | Merck | North Carolina | state | 2009 | $1,579,355 | | tax credit/rebate |
Genentech USA, Inc | Roche | Oregon | state | 2020 | $1,573,000 | | grant |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2007 | $1,570,977 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | United States | federal | 2011 | $1,568,670 | | federal grant |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $1,568,471 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2016 | $1,553,113 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2010 | $1,517,457 | | enterprise zone |
SEATTLE GENETICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $1,515,773 | | tax credit/rebate |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $1,515,349 | | enterprise zone |
Regeneron East Greenbush | Regeneron Pharmaceuticals | New York | local | 2014 | $1,508,236 | | tax credit/rebate |
Merck | Merck | Virginia | state | 2007 | $1,500,000 | | grant |
Medicines Company, The | Novartis | New Jersey | state | 2013 | $1,500,000 | | grant |
MedImmune LLC | AstraZeneca | Maryland | state | 2015 | $1,500,000 | | grant/loan hybrid program |
Merck | Merck | Virginia | state | 2015 | $1,500,000 | | grant |
Sanofi Pasteur Vaxdesign Corp | Sanofi | United States | federal | 2010 | $1,499,990 | | federal grant |
Medimmune, LLC | AstraZeneca | Maryland | state | 2012 | $1,497,096 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2014 | $1,497,096 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2017 | $1,494,073 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2011 | $1,490,125 | | enterprise zone |
MedImmune, LLC | AstraZeneca | Maryland | state | 2019 | $1,475,043 | | tax credit/rebate |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2010 | $1,470,600 | | training reimbursement |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2021 | $1,461,100 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2020 | $1,458,481 | | tax credit/rebate |
SYNTHES U.S.A., LLC | Johnson & Johnson | New York | state | 2012 | $1,457,431 | | enterprise zone |
Bellicum Pharmaceuticals, Inc. | Bellicum Pharmaceuticals | Texas | state | 2007 | $1,450,000 | | grant |
Otsuka America Pharmaceutical, Inc. & Otsuka | Otsuka Pharmaceutical | New Jersey | state | 2009 | $1,449,375 | | grant |
Biogen Idec, MA Inc. | Biogen | Massachusetts | state | 2015 | $1,440,000 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2015 | $1,425,876 | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2013 | $1,421,000 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2012 | $1,416,700 | | enterprise zone |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2009 | $1,405,458 | | tax credit/rebate; property tax abatement |
Novo Nordisk | Novo Holdings A/S | New Jersey | state | 2007 | $1,387,680 | | Tax credit/rebate |
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $1,385,605 | | tax credit/rebate |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $1,384,120 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $1,380,000 | | grant |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2015 | $1,375,894 | | tax increment financing |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $1,375,593 | | tax credit/rebate |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2020 | $1,368,830 | | tax rebate |
Dr. Reddy`s Laboratories | Dr. Reddy's Laboratories | New Jersey | state | 2010 | $1,364,220 | | grant |
GlaxoSmithKline Biologicals North America dba Corixa | GlaxoSmithKline | Pennsylvania | state | | $1,350,000 | | tax credit/rebate |
GlaxoSmithKline Biologicals North America dba Corixa | GlaxoSmithKline | Pennsylvania | state | | $1,350,000 | | grant |
Merrimack Pharmaceuticals, Inc. | Merrimack Pharmaceuticals | Massachusetts | state | 2015 | $1,350,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2018 | $1,350,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2020 | $1,350,000 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | Local | 2018 | $1,349,602 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2019 | $1,338,392 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2013 | $1,336,023 | | tax credit/rebate; property tax abatement |
Daiichi Sankyo, Inc. | Daiichi Sankyo | New Jersey | state | 2004 | $1,330,304 | | grant |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2015 | $1,330,020 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2010 | $1,321,420 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2015 | $1,320,134 | | tax credit/rebate |
Baxalta. Inc. | Takeda Pharmaceutical | Massachusetts | state | 2016 | $1,320,000 | | tax credit/rebate |
Johnson and Johnson Vision Care, Inc. | Johnson & Johnson | Florida | state | 2014 | $1,300,000 | | grant |
Merck Sharpe & Dohme | Merck | Virginia | state | 2016 | $1,300,000 | | grant |
Merck & Co | Merck | Virginia | state | 2016 | $1,300,000 | | grant |
Merck | Merck | Virginia | state | 2019 | $1,300,000 | | grant |